Population pharmacokinetics of recombinant human C1 inhibitor in patients with hereditary angioedema. | Br J Clin Pharmacol;76(6): 897-907, 2013 Dec. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Population pharmacokinetics of recombinant human C1 inhibitor in patients with hereditary angioedema.

Farrell, Colm; Hayes, Siobhan; Relan, Anurag; van Amersfoort, Edwin S; Pijpstra, Rienk; Hack, C Erik.

Affiliation

Farrell C; ICON Development Solutions, Marlow, UK.

Br J Clin Pharmacol ; 76(6): 897-907, 2013 Dec.

Article in En | MEDLINE | ID: mdl-23594263

Subject(s)
Key words

NONMEM; hereditary angioedema; pharmacokinetics; recombinant human C1 inhibitor

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Complement C1 Inactivator Proteins / Hereditary Angioedema Types I and II / Models, Biological Type of study: Prognostic_studies Limits: Humans Language: En Journal: Br J Clin Pharmacol Year: 2013 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Complement C1 Inactivator Proteins / Hereditary Angioedema Types I and II / Models, Biological Type of study: Prognostic_studies Limits: Humans Language: En Journal: Br J Clin Pharmacol Year: 2013 Document type: Article Affiliation country: Country of publication: